• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2018; 42(1) e12-e14

Pubblicato on-line:

February 2, 2018

DOI:

10.19186/BC_2018.012

Scarica in PDF:
Autenticazione richiesta

Un caso insolito di mieloma a catene leggere

AUTORI

Matteo Simoncini1, Antonella Vaccarino1, Maria Pagliaro1, Matteo Cicilano2, Mario Bazzan1
1S.S.V.D. Ematologia, 2Laboratorio Analisi, Ospedale San Giovanni Bosco, Torino

ABSTRACT

An uncommon case of light chain multiple myeloma

A 77-year-old patient with a long-lasting stable proteinuria was admitted to the Nephrology Department for the recent onset of nephrotic syndrome and renal failure. The initial laboratory profile was unremarkable, except for a severe hypogammaglobinemia without monoclonal spike on serum protein electrophoresis. Renal biopsy was performed, showing diffuse amyloidosis; however, immunohistochemistry for light chains was negative, leading to the hypothesis of a genetic amyloidosis. To rule out an AL-type amyloidosis, serum immunofixation and FLC measurement were performed, showing a monoclonal component of lambda light chain with a significant impairment of the kappa/lambda ratio. The bone-marrow biopsy led to the final diagnosis of light chain multiple myeloma. A Bortezomib-based chemotherapy regimen was started, however, despite clinical improvement, lambda free light chains showed a marked increase, leading to a Melphalan-based therapeutic strategy. In conclusion, measurement of FLC ratio was crucial for the diagnosis and the therapeutic monitoring in this troublesome myeloma case.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967